Dr. Reddy’s Laboratories has made an offer of $36 million to acquire OctoPlus, a service-based specialty pharmaceutical company headquartered in the Netherlands. The offer price represents a premium of 30% above the closing price of OctoPlus as of October 19, 2012. This deal will help expand the expertise and scientific capabilities of Dr. Reddy’s. G V Prasad, the company’s vice chairman and chief executive officer, commented, “As we globalize our R&D efforts, we are looking for...